News from our business units
New regulatory requirements are increasing the demands placed on digital sovereignty. Resilience is becoming mandatory.
AI in the regulated GxP environment: Dr Hans Klöcker explains how pharmaceutical companies validate AI solutions and ensure safe, compliant operation.
Transformation Insights
New regulatory requirements are increasing the demands placed on digital sovereignty. Resilience is becoming mandatory.
AI in the regulated GxP environment: Dr Hans Klöcker explains how pharmaceutical companies validate AI solutions and ensure safe, compliant operation.
Neue Artikel
Meet our experts in Madrid from May 19–21, 2026 at booth 9.218 and learn how we apply SAP transformation, cloud, and AI for Life Sciences and Chemicals.
NIS2 makes resilience in the pharmaceutical industry a strategic leadership priority, requiring an integrated operating model that harmonizes compliance, cybersecurity, and business continuity.